Precision Neuroscience Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 56

Employees

  • Latest Deal Type
  • Series C

  • Latest Deal Amount
  • $27.5M

  • Investors
  • 7

Precision Neuroscience General Information

Description

Developer of a brain-computer interface technology designed to provide effective treatments for patients suffering from neurological illnesses. The company's technology is designed to be minimally invasive, safely removable and capable of processing large amounts of data, enabling medical professionals to directly connect the human brain with artificial intelligence.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • 54 West 21st Street
  • Suite 301
  • New York, NY 10010
  • United States
+1 (646) 000-0000

Precision Neuroscience Timeline

202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Precision Neuroscience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series C) 02-Apr-2024 $27.5M 0000 Completed Pre-Clinical Trials
2. Early Stage VC (Series B) 25-Jan-2023 0000 0000 00000 Completed Pre-Clinical Trials
1. Early Stage VC (Series A) 25-May-2021 $12M $12M 0000 Completed Pre-Clinical Trials
To view Precision Neuroscience’s complete valuation and funding history, request access »

Precision Neuroscience Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 00,000,000 00.000000 00.00 00.00 00 00.00 000
Series A 00,000,000 00.000000 00 00 00 00 00.000
To view Precision Neuroscience’s complete cap table history, request access »

Precision Neuroscience Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a brain-computer interface technology designed to provide effective treatments for patients suffering from
Therapeutic Devices
New York, NY
56 As of 2024
0000
00000000000 0000

000000

veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo
00000000000 0000000
Fremont, CA
000 As of 0000
00000
00.000 0000-00-00
00000000000 00000

000000

esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat
0000000000 000000000
Salt Lake City, UT
000 As of 0000
000.00
00000 0000-00-00
000000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Precision Neuroscience Competitors (9)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Neuralink Venture Capital-Backed Fremont, CA 000 00000 00000000000 00000
Blackrock Neurotech Venture Capital-Backed Salt Lake City, UT 000 000.00 000000000000 000.00
Synchron Venture Capital-Backed New York, NY 000 00000 00000000000 00000
Kernel Venture Capital-Backed Los Angeles, CA 00 000.00 0000000000 0 000.00
Paradromics Venture Capital-Backed Austin, TX 00 000.00 00000000000 000.00
You’re viewing 5 of 9 competitors. Get the full list »

Precision Neuroscience Patents

Precision Neuroscience Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240134453-A1 Data-efficient transfer learning for neural decoding applications Pending 24-Oct-2022 000000000
US-20240130682-A1 Secure interfaces for medical devices Pending 20-Oct-2022 0000000000
US-20240131342-A1 High-bandwidth systems for closed-loop deep brain stimulation Pending 20-Oct-2022 00000000000
US-20240131335-A1 High-bandwidth systems for closed-loop signal cord stimulation Pending 20-Oct-2022 00000000000
US-20240137348-A1 Secure interfaces for neural devices Pending 20-Oct-2022 H04L63/0428
To view Precision Neuroscience’s complete patent history, request access »

Precision Neuroscience Executive Team (7)

Name Title Board Seat Contact Info
Brian Otis Chief Technology Officer
Benjamin Rapoport Ph.D Co-founder, Chief Scientific Officer & Board Member
Mark Hettick Ph.D Co-Founder & Head of Microfabrication
Craig Mermel Chief Product Officer, President & Board Member
Demetrios Papageorgiou Ph.D Co-Founder and Senior Vice President of Engineering
You’re viewing 5 of 7 executive team members. Get the full list »

Precision Neuroscience Board Members (7)

Name Representing Role Since
Benjamin Rapoport Ph.D Precision Neuroscience Co-founder, Chief Scientific Officer & Board Member 000 0000
Craig Mermel Precision Neuroscience Chief Product Officer, President & Board Member 000 0000
Eric Attias Forepont Capital Partners Board Member 000 0000
Howard Morgan Ph.D B Capital Group Board Member 000 0000
Jason Chen Ph.D Self Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Precision Neuroscience Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Precision Neuroscience Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Alumni Ventures Venture Capital Minority 000 0000 000000 0
Draper Associates Venture Capital Minority 000 0000 000000 0
Forepont Capital Partners Venture Capital Minority 000 0000 000000 0
Mubadala Capital Asset Manager Minority 000 0000 000000 0
re.Mind Capital Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »

Precision Neuroscience Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Precision Neuroscience (Manufacturing Facility in Dallas, Texas) 05-Oct-2023 000000000 Buildings and Property 0000000 0
To view Precision Neuroscience’s complete investments history, request access »

Precision Neuroscience FAQs

  • When was Precision Neuroscience founded?

    Precision Neuroscience was founded in 2021.

  • Who is the founder of Precision Neuroscience?

    Benjamin Rapoport Ph.D, Mark Hettick Ph.D, Demetrios Papageorgiou Ph.D, and Michael Mager are the founders of Precision Neuroscience.

  • Who is the CEO of Precision Neuroscience?

    Michael Mager is the CEO of Precision Neuroscience.

  • Where is Precision Neuroscience headquartered?

    Precision Neuroscience is headquartered in New York, NY.

  • What is the size of Precision Neuroscience?

    Precision Neuroscience has 56 total employees.

  • What industry is Precision Neuroscience in?

    Precision Neuroscience’s primary industry is Therapeutic Devices.

  • Is Precision Neuroscience a private or public company?

    Precision Neuroscience is a Private company.

  • What is Precision Neuroscience’s current revenue?

    The current revenue for Precision Neuroscience is 000000.

  • How much funding has Precision Neuroscience raised over time?

    Precision Neuroscience has raised $53M.

  • Who are Precision Neuroscience’s investors?

    Alumni Ventures, Draper Associates, Forepont Capital Partners, Mubadala Capital, and re.Mind Capital are 5 of 7 investors who have invested in Precision Neuroscience.

  • Who are Precision Neuroscience’s competitors?

    Neuralink, Blackrock Neurotech, Synchron, Kernel, and Paradromics are some of the 9 competitors of Precision Neuroscience.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »